chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, fever (more than slight( for 2 nights), heavy nausea, dull headache, and feeling fatigue
Had a rash appear  a week and half after my shot. Rash stayed not even for 24 hours and then gone. Rash appeared the first day that I stopped getting text messages to check on my shot process.
Tingling, numbness, pain in feet and hands/fingers 1 week after shot.  Almost 5 months later, finger pain remains. Met with Urgent Care, Primary Dr, Neurologist, and Ortho hand specialist, and acupuncturist to no avail. Terrible nerve damage pain in fingers/hands persist.
5 days after receiving PENTACEL, PREVNAR, HBV, ROTATEQ mother brought pt in for evaluation on 1) swelling of outer thigh involving area including injection site and 2) papules over injection site / surrounding area.
Psoriasis that started the day after the vaccine.  mild in nature. it flared again the day after the 2nd vaccine.
Pain in right arm/shoulder, decreased range of motion at right shoulder, suspected bursitis at right shoulder.
Patient developed pain and swelling in LLE about 2 weeks after receiving vaccine and was diagnosed with DVT.  He has no other risk factors and was initially considered an unprovoked DVT, however, when he shared is vaccine information with us, we felt that it was best to report it.  He was treated with starting dose of Eliquis 10mg BID x7 days and is now on maintenance dose of 5mg BID.
This spontaneous report was received from a physician refers to a male patient of unknown age. On 17-FEB-2014, the patient was vaccinated with the first dose and on 27-MAY-2014, the patient was vaccinated with the second dose of GARDASIL, 0.5 ml, intramuscular. At the time of the report, the patient did not received the third yet. The physician was going to give the patient the third soon. No adverse experiences were reported. Additional information has been requested.
BUMPS ON BACK WITH RAISED CENTER, SUSPECTED BUG BITES INITIALLY. BUMPS HAVE CONTINUED TO SURFACE ON BACK UNTIL PRESENT TIME. VERY ITCHY. NOT BLISTERING, THEY APPEAR AS WELTS, THEN SHRINK BUT REMAIN WITH A RAISED CENTER.
Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old male patient who experienced rash from head to toe. At 1 month of age, the patient received the first dose on 03-Jul-2008. The patient also received the first dose of DAPTACEL (Aventis-Pasteur), the first dose of ROTATEQ (Merck & Co Inc), the first dose of RECOMBIVAX-HB (Merck Sharp & Dome), the first dose of Polio-Vaccine (Not Specified) and the first dose of Hib (manufacturer unknown) on 03-Jul-2008. Relevant medical history was not provided. Concomitant medications were not reported. The patient experienced rash from head to toe on 08-Jul-2008. There was no fever or other symptoms. The rash lasted 2 weeks and the patient recovered. No additional information was available at the time of this report. See related case(s): US-WYE-H06087008 (adverse event, non-expedited).
itchy rash in several areas several days post vaccination starting under armpit and also in several other places in body including other armpit hip and side.
Narrative:  73y.o. MALE with a h/o bladder cancer with pelvic and intra-abdominal lymph node metastases with a h/o bladder cancer with pelvic and intra-abdominal lymph node metastases in home hospice care died at home on 12/22/2021. Pt had received covid vaccines on 1/7/21, 2/4/21, & 10/12/21. This death is not related to covid vaccines.
pt recv vax 3MAY96 & 12MAY96 pt devel sl red typical measles like rash on stomach, back & arms & fever of 101.2 x 3 days;pt was exposed to strep;cult was negative for group A Beta Strep;
Patient is under age and received a COVID vaccine. Patient is 13 years old. Patient was monitored as any COVID patient for 15 mins after dose and had no reaction. Patient had nurse calls mad to mom for a week after vaccine to monitor him. Mom states she has seen no reactions with patient.
Bell's Palsy; This is a spontaneous report from a contactable other health professional. A female patient of an unspecified age (age: 34; unit: unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced bell's palsy in Jan2021 with outcome of unknown. The patient who received first dose of vaccine on Saturday and woke up this morning with Bell's Palsy as confirmed by urgent care. She is wondering about the clinical trial participants and if she can receive the second dose.    Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Patient presents with right arm erythema approx 4"x 4". Origination appears to be at the lateral mid-deltoid region and extends distally to approx 3" proximal to the elbow/antecubital fossa. Localized erythema does not extend past elbow joint nor shoulder joint. Area is tender on palpation with normal skin temperature. No warmth, exudate or excoriations appreciated on examination. Neg axillary LAD.
body ache; headaches; chills; didn't feel well; This is a spontaneous report from contactable consumer (patient mother) via a Pfizer sponsored program. A female patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiration date was not reported) via an unspecified route of administration on an unspecified date (reported as 3 weeks ago) as a single dose for COVID-19 immunization. No patient identifiers were provided but the reporter has first-hand knowledge of the patient. Medical history and concomitant medications were not reported. On an unspecified date, after first dose patient experienced headaches, body aches, chills and didn't feel well. Reporter stated that the vaccination site was shut down due mishandling of the vaccine and had received letters from the state that they need to begin the vaccination series again. Reporter inquired safety or wisdom of receiving potentially a third dose of the vaccine 3 weeks in a row. The caller wants to know if that was correct and if her daughter should get the vaccine because she had reactions the first time. Outcome for the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in an adult subject of unspecified gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On an unspecified date the subject received 3rd dose, 2nd dose and 1st dose of ENGERIX B (unknown). At an unspecified time after vaccination series completion with ENGERIX B, the subject experienced not responding to therapy and pharmaceutical product complaint. A total of six employees were vaccinated with three doses of ENGERIX B. All had titers drawn at an unknown period after the third dose and the titers were negative (0) for antibodies. There were two lots given to these six subjects at some point in the series, lots: AHBV13734AA and AHBV670AA. The lot numbers were reported as AHBV13734AA and AHBV670AA from the reporter; however, based on a safety lot number review, the lot numbers were updated to AHBVB734AA and AHBVB670AA respectively. For the other cases see A0891212A, A0891214A- A0891217A. Follow-up information was received on 09November 2010 via Quality Assurance, who stated there was no product complaint associate with the adverse event; therefore the pharmaceutical product complaint was voided.
Pt experienced a fever the evening of 3/7/00, the same day as vax. Pt developed a fever of 103 (per pts dad). On 3/8/00 a hard knot with swelling of the arm was noted. Pt complained of increased soreness and aching in the right arm. Denies rash or other symptoms. Pt's arm had a swollen hard knot at injection site, approximately 3 mm with reddened area. Will monitor. Treated with Benadryl, Tylenol/Motrin, warm packs.
Information was received from a pharmacist that pt post vaccine pt experienced local site reaction, generalized rash of injected arm and also opposite arm (site of previous vaccine). Follow up states on 11/18/2000 the patient recovered from the rash. Unspecified medical attention was sought. No further information is expected.
Patient diagnosed with Thyroid Condition; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), in Oct2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 Immunization.  The following information was reported: THYROID DISORDER (non-serious), outcome "not recovered", described as "Patient diagnosed with Thyroid Condition". Therapeutic measures were taken as a result of thyroid disorder.  Additional information: It was reported that patient received a medication as treatment for thyroid condition. It was unknown if patient had covid prior vaccination. It was also unknown if patient was covid tested post vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information was received on 28-JUN-2017 from a physician via a company representative regarding a 28 year old female student. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient needed to get the VARIVAX, but was mistakenly given Zoster Vaccine Live. The outcome of the event was unknown. No other details were available. No PQC was involved. Additional information is not expected.
HARD KNOT, WARM TO TOUCH, RED, EDEMA AND PAIN AT INJECTION SITE
At local store was given Fluzone HD PF 19-20 inj sq R arm and Prevnar 13 inj IM L arm 10/14/19. Experienced L arm deltoid edema,pain > R arm, chills first day, 2nd day fatigue/malaise and headache. Went to primary care a week later for another issue and was surprised to find that my b/p which normally runs 130s/80s was now 140s/101 -90s, pulse in 90s. Have had continuing low grade headache and elevated b/p since. Since a rare s/e of Pneumovax has been CVA and I have experienced continuing elevated (unusual for me) b/p since Pneumovax was given 22 days ago, I have concerns about this vaccine. I won't be taking the sequel 13.
Patient reported severe pain and cramps around calf-muscle, pt reported to a local hospital for the pain
BODY ACHES; CHILLS; FEVER; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol user, and non smoker, and other pre-existing medical conditions included patient had no known drug allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, fever, nausea, and headache on 14-APR-2021. This report was non-serious.
Initial report received from a consumer on 21 June 2011. A 53-year-old female patient received a right deltoid injection (dose 1) of ADACEL, sanofi pasteur lot number unknown on 03 March 2011. The patient had allergies which included egg, milk, yeast, cheese, bananas, green beans and clams. The patients' concomitant medications included MUCINEX, PEPCID; fish oil, PROSOM, PROTONIX and SINGULAIR. The patient had no illness at the time of vaccination. A few weeks after the vaccine (mid April) the patient developed nasal and sinus congestion and other allergy symptoms which still persists. The outcome was reported as not recovered. Follow-up information was received from a health care professional on 02 August 2011. The patient had received ADACEL, lot number C3727AA in the left deltoid on 31 March 2011 (previously reported as the right deltoid and received on 03 March 2011). According to the reporter, the patient had contacted their office on 21 June 2011 with concerns about her asthma attacks. The patient thought that the attacks could possibly had been be related to the ADACEL she had received. The reporter noted that the spring in their area had been very bad for allergy sufferers stating that they had many individuals that reported to employee health with symptoms of nasal and head congestion, sinus congestion, itching eyes, post nasal drip, HA (headaches) and earaches. The patient stated she was aware of media reports of this spring being very bad for allergies. The patient reported that she had seen her primary care physician and was referred to a pulmonary specialist. She reported that she only felt better in the house with air conditioner and when she went outside she would wear a mask. The patient reported a history of mild asthma with inhaler use, sinus surgery and allergy shots 14 years prior that she stopped after she had a "bad reaction to them" stating she had a bout of bronchitis. She also reported that two years prior she had been exposed to smoke from fireworks and it took her eight months to return to "normal". At that time she was evaluated by a pulmonologist and it found that her lungs were at "66% of their flow". No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: None.
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine (diphtheria crml97 protein) injection) was received from a mother regarding her 6 month old son who developed a mild fever 101 degrees, and swelling at the injection site, the size of a quarter. The patient received the third dose on 12/15/2003/ Event Details: Post immunization the pt develped a mild fever and swelling at the injection site the size of a quarter. Related Cases"HQWYE173023DEC04, HQWYE279829DEC04, and HQWYE279929DEC04. No additonal information was available at the time of this report.
I experienced 72 hours afterwards, lymph glands very painful both on the groin and underarms. These lasted for ten days. Since then, I have had rotating inflammatory joint pain, gum pain, called multi system inflammatory response.  I sometimes can not get out of bed and my knee hurts so bad. Then it might go to my gums, wrists and ankles, it seems to hurt my joints. I have no immune system. I can to take any live vaccines due to my immune system. My PCP doctor advised me not to take the Moderna vaccine. I also have an immunologist had a visit, Dr. still having the inflammation effects.
Arm pain at injection site. Has become sore arm with decreased movement. Arm continues to hurt with movement or while stationary. Saw dr who did X-ray and MRI. Referred for physical therapy.
Disseminated, non-systemic vaccinia. Multiple round erythematous lesions varying in size from 1 cm to 4 cm on legs, arms and trunk.
pt devel swollen rt thigh & fever t 102.7;pt vomiting as well;only rt thigh red/swollen;
COVID infection following COVID vaccine series 01/27, Moderna , dose #1 02/25, Moderna , dose #2 11/13 COVID swab, result: detected 11/13 pt cc: asymptotic exposure: unknown
Patient with history of COVID vaccines who admitted to hospital with COVID detcted PCR. Provider d/c note: "COVID-19 Was screen to have roommate -Asymptomatic, reported positive 1/23, likely residual"
Per pt 3 hours after shot on Monday 5/21/18 patient noticed symptoms of migraine, soreness, and back pain centered around the spine. As the day progressed to the next day the symptoms only got worse. She also developed fever, redness, and swelling around the injection site. As of today 5/23/18 she is only sore now.
Pt received a flu vaccine on 10/23/2019 at Flu event held at clinic. Lot # 3RL4J given in the left deltoid. Pt texted rn photos of progressive swelling at the injection site. Pt advised, per Clinical Director, to take Benadryl and follow up with PCP if symptoms persist or worsen. Spoke with client 10/28/2019 and swelling has resolved and pt states she still has some itching at the injection site. Pt denied any fever, chills or difficulty breathing. Pt did not need to seek any additional medical care or consult as swelling and redness resolved.
Client received 2nd dose in primary pediatric Pfizer vaccine series. Client was seated in chair when receiving vaccination. Approximately 2 minutes after administration, client lost consciousness, bumped head on back of chair and was lowered to the floor by parent and vaccinator. Client lost consciousness for approximately 15 seconds, but became fully responsive immediately after and was able to recall events prior to loss of consciousness. Vital signs were within appropriate ranges. An ice pack was provided for the client's head, client had no complaints of concussion symptoms. Client was given a juice box and pretzels. Client remained in the exit area for 30 minutes to monitor for further adverse events. Client improved with food and drink and was released into the care of parent with recommendation to follow up with pediatrician if new symptoms present or worsen.
I was employed by Hospital in 1984 at age 21. in providing my immunization records, we believed I had never had chicken pox. I was born in 1964 , I could not remember having the chicken pox and my mother said I did not have it. The hospital health office drew a titer and confirmed I had no immunity to the virus. I was not allowed in rooms with shingles or chicken pox patients. After the chicken pox vaccination became available I received it from my employer, this was approximately 1997 . I was approx. 33 years old at that time. I changed employers in January 2023, and the hospital I moved to drew blood to see what immunizations I would need. My new employer advised me my labs shown that I have no immunity to the chicken pox virus and gave me in the 2 dose, 30 days apart vaccine. I am just sharing this with you because I thought it might be helpful information on the duration and effectiveness of the first chicken pox vaccine that first came out, ( I believe it was new for children and adults in 1995). It did not give me lifelong immunity. I am 58 years old now and have been offered the shingle vaccination, but I feel I should not need it if I have never had the chicken pox virus. thank you.
Headache, MUSCLE BODY ACHES LOWER BACK CHILLS Narrative:
Strong chills set in around 2:30 PM. I ended up getting a fever that spiked at 103 and lasted on and off for 12 hours. The following morning the fever and chills were gone. I felt extremely fatigued.
Reported today --> full body hives on 11/8/13 after 1st dose of HPV given. Full body hives and chest pain on 01/10/14 after 2nd dose given.
Throat tightening. 1. Pt. had Benadryl (personal ) 50 mg liquid post c/o throat @2:54 Albuterol HFA 2 puffs and Epi 1:1- 0.5 mgs . Patient. continued coughing.  2. EMT unit was called in.  Pt. was given 0 EKG, provided for transport.  Pt. was transported to hospital for respiratory support and evaluation @AAMC at 3:15 p.m.
Instantaneously my BP shot up to 250/180, massive headache, nauseous and dizziness. Paramedics on-site assessed me for an hour. I was sent home. On March 3, 2021, I had chest pain, and called 911. I was hospitalized for a week. They thought I could be having a heart attack. Stress test was borderline. Blood levels didn't indicate a heart attack. After a week, they sent me home. April 10th, I started having trouble breathing. April 12th, my breathing became even more difficult. April 14th, I had trouble breathing again. I was near a doctors office, they did an EKG, which indicated I was having a heart attack. An ambulance was called. April 16th, I had open heart surgery. April 17 & 19th, stents were placed. I was 10 days in the hospital the second time.
A large circular, red, itchy lesion appeared at the vaccination site. It was swollen and hard to the touch. It grew overnight and into the next day reaching a diameter about 4 inches. It healed and disappeared after 3 days. Itchy hives on the buttocks, back, and stomach occurred at the same time,  appearing each night for 6 days. Benadryl was used on nights 3 and 4, and hives persisted.
Narrative: 71 y/o pt with newly diagnosed esophageal cancer had received first dose of Pfizer COVID-19 vaccine on 2/23/2021. Pt was then diagnosed with stage IV metastatic GEJ adenocarcinoma on 3/2 and surgery was performed on 3/11. Pt was later admitted on 3/19-3/21 for s/s of GI bleed and discharged on 3/21 per pt's insistence. On 3/22, pt was admitted 3/22 to non-facility hospital for acute blood loss and then stroke. Pt was then discharged to rehab facility. Pt was admitted on 4/12 due to SOB and then diagnosed pneumonia. Pt was then found to have NSTEMI. Pt expired 4/18.
Heart was pounding for about 5min; Heartbeat was fast and racing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Heart was pounding for about 5min) and HEART RATE INCREASED (Heartbeat was fast and racing) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included SODIUM BICARBONATE, POTASSIUM, SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), GLIPIZIDE, PREDNISOLONE (PRESOLONE [PREDNISOLONE]), SIMVASTATIN and CALCITRIOL (CALCITROL [CALCITRIOL]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PALPITATIONS (Heart was pounding for about 5min) and HEART RATE INCREASED (Heartbeat was fast and racing). At the time of the report, PALPITATIONS (Heart was pounding for about 5min) and HEART RATE INCREASED (Heartbeat was fast and racing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Heart rate: fast and racing High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications include melodium mesylate 5mg, Metropical 100mg twice a day, Alloprenol 100mg per day, Fucimide and Levronoxyl 0.25mg.
Swelling near the injection site, large, bruised-looking, raised area the size of a palm. I don't usually have any bruising from needle sticks (I have regular IV's and blood draws due to medical condition). Swelling was extremely painful.